...
首页> 外文期刊>Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases >Differential roles of an Anopheline midgut GPI-anchored protein in mediating Plasmodium falciparum and Plasmodium vivax ookinete invasion
【24h】

Differential roles of an Anopheline midgut GPI-anchored protein in mediating Plasmodium falciparum and Plasmodium vivax ookinete invasion

机译:按蚊中肠GPI锚定蛋白在介导恶性疟原虫和间日疟原虫钩虫侵袭中的差异作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Novel strategies to directly thwart malaria transmission are needed to maintain the gains achieved by current control measures. Transmission-blocking interventions (TBIs), namely vaccines and drugs targeting parasite or mosquito molecules required for vector-stage parasite development, have been recognized as promising approaches for preventing malaria transmission. However, the number of TBI targets is limited and their degree of conservation among the major vector-parasite systems causing human disease is unclear. Therefore, discovery and characterization of novel proteins involved in vector-stage parasite development of Plasmodium falciparum and Plasmodium vivax is paramount. We mined the recent Anopheles gambiae midgut lipid raft proteome for putative mosquito-derived TBI targets and characterized a secreted glycoconjugate of (u) under bar nknown function, AgSGU. We analyzed molecular variation in this protein among a range of anopheline mosquitoes, determined its transcriptomic and proteomic profiles, and conducted both standard and direct membrane feeding assays with P. falciparum (lab/field) and P. vivax (field) in An. gambiae and Anopheles dirus. We observed that alpha-AgSGU antibodies significantly reduced midgut infection intensity for both lab and field isolates of P. falciparum in An. gambiae and An. dirus. However, no transmission-reducing effects were noted when comparable concentrations of antibodies were included in P. vivax-infected blood meals. Although antibodies against AgSGU exhibit transmission-reducing activity, the high antibody titer required for achieving 80% reduction in oocyst intensity precludes its consideration as a malaria mosquito-based TBI candidate. However, our results suggest that P. falciparum and P. vivax ookinetes use a different repertoire of midgut surface glycoproteins for invasion and that alpha-AgSGU antibodies, as well as antibodies to other mosquito-midgut microvillar surface proteins, may prove useful as tools for interrogating Plasmodium-mosquito interactions. (C) 2014 Elsevier B.V. All rights reserved.
机译:需要直接制止疟疾传播的新策略,以维持当前控制措施所取得的成果。传播阻断干预(TBI),即针对媒介阶段寄生虫发展所需的针对寄生虫或蚊子分子的疫苗和药物,已被认为是预防疟疾传播的有前途的方法。但是,TBI靶标的数量有限,在引起人类疾病的主要媒介-寄生虫系统中它们的保守程度尚不清楚。因此,至关重要的是发现和表征恶性疟原虫和间日疟原虫的载体阶段寄生虫发育的新型蛋白质。我们挖掘了最新的冈比亚按蚊中肠脂质筏蛋白质组作为推定的蚊子来源的TBI目标,并在已知功能(AgSGU)下表征了(u)的分泌糖缀合物。我们分析了该蛋白在一系列按蚊中的分子变异,确定了其转录组和蛋白质组学特征,并在加利福尼亚州利用恶性疟原虫(实验室/田间)和间日疟原虫(田间)进行了标准和直接膜饲喂测定。冈比亚和按蚊。我们观察到α-AgSGU抗体显着降低了恶性疟原虫实验室和野外分离株的中肠感染强度。冈比亚和安。迪鲁斯但是,当间日疟原虫感染的血粉中包含相当浓度的抗体时,没有发现降低传播的作用。尽管针对AgSGU的抗体表现出降低传输的活性,但实现卵囊强度降低80%所需的高抗体滴度却使其无法考虑作为基于疟疾蚊子的TBI候选物。但是,我们的研究结果表明,恶性疟原虫和间日疟原虫共分泌物使用不同的中肠表面糖蛋白进行入侵,并且α-AgSGU抗体以及其他蚊中肠微绒毛表面蛋白的抗体可能被证明是有用的工具询问疟原虫-蚊子的相互作用。 (C)2014 Elsevier B.V.保留所有权利。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号